Acute blindness during treatment of recurrent or metastatic nasopharyngeal carcinoma with doxorubicin and CCNU.
Schornagel
J H
JH
Verweij
J
J
de Mulder
P H
PH
Wildiers
J
J
Kirkpatrick
A
A
Cognetti
F
F
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001766:Blindness / Q000139:chemically induced*; D004317:Doxorubicin / Q000009:adverse effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008130:Lomustine / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy*
D008130:Lomustine; D004317:Doxorubicin